title: Three pathways for human kidney stone formation.
abstract: No single theory of pathogenesis can properly account for human kidney stones, they are too various and their formation is too complex for simple understanding. Using human tissue biopsies, intraoperative imaging and such physiology data from ten different stone forming groups, we have identified at least three pathways that lead to stones. The first pathway is overgrowth on interstitial apatite plaque as seen in idiopathic calcium oxalate stone formers, as well as stone formers with primary hyperparathyroidism, ileostomy, and small bowel resection, and in brushite stone formers. In the second pathway, there are crystal deposits in renal tubules that were seen in all stone forming groups except the idiopathic calcium oxalate stone formers. The third pathway is free solution crystallization. Clear examples of this pathway are those patient groups with cystinuria or hyperoxaluria associated with bypass surgery for obesity. Although the final products may be very similar, the ways of creation are so different that in attempting to create animal and cell models of the processes one needs to be careful that the details of the human condition are included.
authors.affiliation: Department of Medicine, University of Chicago, Nephrology Section/MC 5100, 5841 South Maryland Avenue, Chicago, IL, 60637, USA. fcoe@uchicago.edu
authors.forename: Fredric L
authors.initials: FL
authors.lastname: Coe
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Evan
authors.forename: Elaine M
authors.initials: EM
authors.lastname: Worcester
authors.forename: James E
authors.initials: JE
authors.lastname: Lingeman
mesh_terms: D002129:Calcium Oxalate / Q000378:metabolism*; D006801:Humans; D007668:Kidney / Q000473:pathology*; D007669:Kidney Calculi / Q000378:metabolism* / Q000503:physiopathology; D053495:Osteopontin / Q000378:metabolism*
chemical_list: D053495:Osteopontin; D002129:Calcium Oxalate
references.citation: Kidney Int. 2007 Apr;71(8):795-801
references.pmid: 17264873
references.citation: Kidney Int. 2003 Dec;64(6):2150-4
references.pmid: 14633137
references.citation: Am J Physiol Renal Physiol. 2007 Jan;292(1):F66-75
references.pmid: 17210796
references.citation: J Urol. 2006 May;175(5):1720-4; discussion 1724
references.pmid: 16600740
references.citation: J Clin Invest. 2003 Mar;111(5):607-16
references.pmid: 12618515
references.citation: Kidney Int. 2004 Aug;66(2):777-85
references.pmid: 15253733
references.citation: Kidney Int. 2006 Apr;69(8):1313-8
references.pmid: 16614720
references.citation: Anat Rec (Hoboken). 2008 Mar;291(3):325-34
references.pmid: 18286613
references.citation: Am J Physiol Renal Physiol. 2009 Oct;297(4):F1017-23
references.pmid: 19640901
references.citation: Anat Rec (Hoboken). 2007 Oct;290(10):1315-23
references.pmid: 17724713
references.citation: Am J Physiol Renal Physiol. 2008 Nov;295(5):F1286-94
references.pmid: 18715937
references.citation: Kidney Int. 2009 Nov;76(10):1081-8
references.pmid: 19710630
references.citation: Kidney Int. 2006 Jun;69(12):2227-35
references.pmid: 16710357
references.citation: Nephrol Dial Transplant. 2009 Jan;24(1):130-6
references.pmid: 18662977
references.citation: Kidney Int. 2005 Jul;68(1):145-54
references.pmid: 15954903
references.citation: Kidney Int. 2003 Jan;63(1):255-65
references.pmid: 12472791
references.citation: Kidney Int. 2005 Feb;67(2):576-91
references.pmid: 15673305
references.citation: Kidney Int. 2008 Jul;74(2):223-9
references.pmid: 18449170
references.citation: Kidney Int. 2007 Dec;72(12):1503-11
references.pmid: 17898697
references.citation: J Urol. 1989 Apr;141(4):819-21
references.pmid: 2926871
references.citation: BJU Int. 2009 Mar;103(5):670-8
references.pmid: 18793297
references.citation: BJU Int. 2009 Apr;103(7):966-71
references.pmid: 19021625